334 related articles for article (PubMed ID: 19914319)
1. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
Wong HL; Chattopadhyay N; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
[TBL] [Abstract][Full Text] [Related]
2. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
Gupta U; Jain NK
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
Ronaldson PT; Persidsky Y; Bendayan R
Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
[TBL] [Abstract][Full Text] [Related]
4. Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.
Al-Ghananeem AM; Smith M; Coronel ML; Tran H
Expert Opin Drug Deliv; 2013 Jul; 10(7):973-85. PubMed ID: 23510097
[TBL] [Abstract][Full Text] [Related]
5. Role and modulation of drug transporters in HIV-1 therapy.
Alam C; Whyte-Allman SK; Omeragic A; Bendayan R
Adv Drug Deliv Rev; 2016 Aug; 103():121-143. PubMed ID: 27181050
[TBL] [Abstract][Full Text] [Related]
6. Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.
Fiandra L; Capetti A; Sorrentino L; Corsi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):17-30. PubMed ID: 27832401
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of HIV-1 drug resistance in the neurological compartment.
Antinori A; Cingolani A; Giancola ML; Forbici F; De Luca A; Perno CF
Scand J Infect Dis Suppl; 2003; 106():41-4. PubMed ID: 15000582
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
9. Nano-ART and NeuroAIDS.
Das MK; Sarma A; Chakraborty T
Drug Deliv Transl Res; 2016 Oct; 6(5):452-72. PubMed ID: 27137528
[TBL] [Abstract][Full Text] [Related]
10. Progress in antiretroviral drug delivery using nanotechnology.
Mallipeddi R; Rohan LC
Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
[TBL] [Abstract][Full Text] [Related]
11. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.
Kis O; Robillard K; Chan GN; Bendayan R
Trends Pharmacol Sci; 2010 Jan; 31(1):22-35. PubMed ID: 20004485
[TBL] [Abstract][Full Text] [Related]
12. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
Gupta S; Kesarla R; Omri A
Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
[TBL] [Abstract][Full Text] [Related]
13. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
14. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
[TBL] [Abstract][Full Text] [Related]
17. Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.
Ashraf T; Robillard K; Chan GN; Bendayan R
Curr Pharm Des; 2014; 20(10):1543-63. PubMed ID: 23789949
[TBL] [Abstract][Full Text] [Related]
18. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
19. Past, Present, and Future Drug Delivery Systems for Antiretrovirals.
Kirtane AR; Langer R; Traverso G
J Pharm Sci; 2016 Dec; 105(12):3471-3482. PubMed ID: 27771050
[TBL] [Abstract][Full Text] [Related]
20. The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.
Varatharajan L; Thomas SA
Antiviral Res; 2009 May; 82(2):A99-109. PubMed ID: 19176219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
